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Abstract
Human prostate cancer LNCaP cells including C-33 and C-81 cells were originally derived from the
lymph nodes of a patient with metastatic prostate cancer. These two cells were employed for
characterization of L-selectin ligand and in vitro tumorigenicity, because they mimic the clinical
conditions of early and late-stage human prostate cancer. C-81 cells exhibit higher in vitro migratory
and invasive properties as compared with C-33 cells. We find that the L-selectin ligand and mucin
glycan-associated MECA-79 epitope were elevated in C-81 cells. An increase of these glycotopes
positively correlates with elevated tumorigenicity and expression of key glycosyl- and
sulfotransferase genes. These results suggest that modulated expression of selective glycogenes
correlates with altered tumorigenicity of cancer cells.
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Introduction
Prostate cancer is the most common solid tumor in men in the US and Western Europe, and
the second most common cause of cancer-related death in men over age 55 [1]. Metastasis to
the brain, bone and lymph nodes is the main cause of prostate cancer death [2]. However, the
molecular mechanism by which the late-stage prostate cancer cells metastasize to the distant
sites is not completely understood. One possible mechanism involves interactions of P-selectin
on platelets and L-selectin on leukocytes with their respective ligands on hematogeneously
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disseminating tumor cells to form microemboli to facilitate their arrest in the vasculature of
their target sites [3]. Such interactions are similar to the mechanisms employed by leukocytes
for migration to the sites of tissue injury and lymphoid tissues [4]. These processes rely on
interactions between P-selectin on the endothelial cells and sialyl Lewis x (sLex) on mucin
glycan and sulfated tyrosine located at the N-terminal region of P-selectin glycoprotein
ligand-1 on the leukocytes, and between L-selectin on the surface of leukocytes and the
glycotopes that contain MECA-79 antigen in the high endothelial venues [5–7], respectively.
Altered glycosylation, which leads to increased production of sLex, has been observed in
advanced cancers [8], including prostate cancer [9]. Since sLex is an essential component of
the selectin ligands, elevation of sLex coupled with expression of GlcNAc 6-sulfotransferase
could enable the cancer cells to utilize the normal leukocyte migration mechanisms to
metastasize [10–13].
In this communication, we provide evidence that supports the hypothesis that expression of L-
selectin ligand on LNCaP cells plays a key role in leukocyte-mediated metastasis to the lymph
nodes. To achieve this goal, we employed a LNCaP cell progression model, including C-33
and C-81 LNCaP cells [14,15]. The properties exhibited by these two cell clones mimic the
early and the late stages of human prostate cancer in the clinic. Thus, this is a useful in vitro
cell model for studying the mechanisms of clinical progression of prostate cancer. As compared
with C-33 cells, C-81 cells have higher proliferation rate, tumorigenicity, and androgen-
independent secretion of prostate-specific antigen. In this study, we show that as compared to
C-33 cells, C-81 cells exhibit a greater degree of in vitro migratory and invasive properties,
elevated expression of L-selectin ligand, and increased expression of key glycogenes involved
in the synthesis of this ligand. Thus, modulation of selective glycogenes in cancer cells could
modify the selectin ligands to alter the metastatic potential of these cells. This property
resembles the known tumorigenic trend of these two cell clones.
Materials and methods
Cell lines
The human prostate cancer LNCaP cell line was originally purchased from the American Type
Culture Collection ATCC (Rockville, MD). The C-33 and C-81 LNCaP cell model used in the
present study was previously developed [15] and characterized [14]. C-33 cells include cells
between passages 25 and 35, and C-81 cells include cells between passages 81 and 125. These
cells were maintained at 37°C under a 5% CO2 and water saturated environment in RPMI 1640
supplemented with 5% fetal bovine serum, 2 mM L-glutamine, 100 units/ml Penicillin and 100
g/ml Streptomycin.
Motility and invasion assays
Motility assay of C-33 and C-81 cells was performed using 24-well plate insert chambers.
Briefly, 5 × 104 cells suspended in 1 ml medium were plated on the top chamber of noncoated
polyethylene terapthalate (8 m pore size, Becton Dickinson, Bedford, MA). After incubation
at 37° C for 24 h in a 5% CO2 and water saturated environment, the cells that did not migrate
through the pores were removed by scraping with a cotton swab. Cells that transversed the
membranes were stained with a Diff-Quick cell staining kit (Dade Behring, Inc., Newark, DE).
Cells at three random fields per insert were counted with a phase contrast microscope at 40×
magnification and expressed as an average number of cells per field of view. Three independent
inserts were analyzed in each case. The data were expressed as mean±SD. Invasion experiment
of C-33 and C-81 cells was carried out using 24-well BD BioCoat™ Matrigel™ invasion
chambers (8 m pore size; Becton Dickinson). Briefly, 5 × 104 cells suspended in 1 ml medium
were seeded on top of the rehydrated Matrigel insert membrane. The cells were incubated for
22 h as described above and then the cells that did not migrate through the pores were removed
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by scraping with a cotton swab. Cells that transversed the membranes were stained with a Diff-
Quick cell staining kit (Dade Behring, Inc., Newark, DE) and counted as described above.
Western blot analysis of MECA-79 epitope and C1 3GalT-1
Whole cell lysates of C-33 and C-81 cells were used for detection of MECA-79 epitope and
C1 3GalT-1 enzyme. Aliquots of the whole cell lysates were boiled in a SDS buffer and
resolved by SDS-Polyacrylamide gel electrophoresis (PAGE) on 8–10% gels, and blotted onto
Immobilon-P membranes (0.45 m pore size, Millipore, Bedford, MA). Membranes were
blocked with 5% bovine serum albumin (BSA) in TBS/Tween for 1 h at RT, and treated at 4°
C overnight with 3% BSA in TBS/Tween containing biotinylated rat anti-mouse MECA-79
epitope monoclonal antibody (Becton Dickinson, Biosciences; 2.5 g/ml) or mouse polyclonal
C1 3GalT-1 antibody (Abnova Corporation, Taipei, Taiwan; 0.01 g/ml). After washing with
TBS/Tween three times at 5 min each, these membranes were treated with HRP conjugated
streptavidin (Zymed laboratories, San Francisco, CA; 1:1,000) and HRP conjugated goat anti-
mouse antibodies (Santa Cruz Biotechnology, Inc, San Diego, CA; 1:2,000 dilution),
respectively. The bound HRP was treated with the enhanced Chemiluminescent substrate,
SuperSignal West Pico Chemiluminescent Substrate (Pierce, Rockford, IL), and then detected
according to the manufacturer's instructions.
Enzymatic characterization of the properties of MECA-79 epitope
Aliquots of cell lysates were digested with O-sialoglycoprotein endopeptidase (OSGP)
(Cedarlane, Ontario, Canada) according to the manufacturer's instructions. Briefly, whole cell
lysates were incubated with OSGP (50 l/50 g protein) at 37°C for 18 h. The cell lysates so
treated were resolved on 8–10% SDS-PAGE and blotted onto Immobilon-P membranes. These
membranes were treated with MECA-79 antibody and then analyzed as described above.
Flow cytometry analysis of L-selectin interactions with LNCaP cells
Flow cytometry analysis of L-selectin interactions with LNCaP cells was carried out as
described previously [16]. Briefly, LNCaP Cells were detached from plates by incubation with
PBS containing 2 mM EDTA for 5 min at 37°C and washed three times with Hanks' balanced
salt solution (HBSS). The cells were treated with 0.5% BSA in HBSS for 30 min to block
nonspecific sites before exposure to L-selectin as described next. The L-selectin used was a
chimera of L-selectin fused with Fc region of human IgG purified from LSRg293 Cytel cells
[16] (A kind gift from Dr. Ajit Varki, University of California at San Diego, La Jolla, CA).
The L-selectin (50 g/ml) was preincubated with a goat-anti human IgG conjugated with FITC
for 1 h at room temperature before incubation with tumor cells at 4°C for 2 h. After washing
with HBSS/BSA and HBSS, the cells were fixed with 2% (wt./vol.) paraformaldehyde in HBSS
for 5 min. Cells were washed again with HBSS and resuspended in 1 ml of HBSS/BSA for
flow cytometry analysis. Controls were stained in the presence of 5 mM EDTA (calcium
chelation). Cells incubated with secondary antibody alone served as antibody control.
RT-PCR analysis of the expression of glycosyltransferase and sulfotransferase genes
Total cellular RNAs were isolated from C-33 and C-81 cells using the TRI-REAGENT
(Molecular Research Center, Inc, Cincinnati, OH) according to the manufacturer's protocol.
For cDNA synthesis, 2 g of total RNA was used as the template in a 20 l RT reaction mixture
by using Reverse-iT™ 1st strand synthesis kit (ABgene, UK) according to the manufacturer's
instructions. The RT-PCR reaction was performed in an Eppendorf Mastercycler Personal
using 1 l of cDNA template in a total volume of 25 l. RT-PCR of key Glyco- and
Sulfotransferase genes involved in the synthesis of 6-sulfo-sLex and -actin were carried out
by using sense and anti-sense primers as shown below: C2GnT-1, 5 -CTCGAAA
CACCTCTCTTTTCTGGC-3  and 5 -GGTCAGTGTTT TAATGTCTCCAAAG-3
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(NM_001097633); 3GnT-3, 5 -TTCTTCA ACCTCACGCTCAAGCAG-3  and 5 -AGCA
TCTCATAAGGTAGGAAGCGG-3  (NM_01425 6); 4GalT-1, 5 -
AGTGACGTGGACCTCATTCC and 5 -CCGA TGTCCACTGTGATTTG-3  (NM_001497);
4GalT-4, 5 -GCTGTTGACTTTGTGCCTGA-3  and 5 -GCCT GGTGGATG
ACGTAGAT-3  (NM_003778); FUT7, 5 -CACCTCCGAGGCATCTTCAACTG-3  and 5 -
CGTT GGTATCGGCTCTCATTCATG-3  (NM_004479); GlcNAc6ST-1, 5 -
CGTGAGAGCC TACAGGTGGT-3  and 5 -CATGGGCTGGTAGCAAAACT-3
(NM_004267.3); ST3Gal-III, 5 -ACTCCAGTGGGAGGAGGACT-3  and 5 -
CGTGACCCCAGAGACTTGTT-3  (NM_1749 63); ST3Gal-IV, 5 -
CTAGCCATCACCAGCTCCTC-3  and 5 -CCAT GAAGAAGGGG TTGAGA-3
(NM_006278) and -actin, 5 -GTGGGGCGCCCCAGGCACCA-3  and 5 -CTCC TTA
ATGTCACGGACGATTC-3  (NM_001101). The PCR reaction conditions for all the genes
were as follows: 94°C for 2 min (1 cycle); 94°C for 30 s, 50°C for 30 s, and 72°C for 1 min
(30 cycles); and then 72°C for 5 min. The expression of glycosyltransferase and
sulfotransferase genes was normalized with the expression of -actin gene, which remained
constant in all samples. The PCR products were subject to electrophoresis (130 V, constant-
voltage field) on 1% agarose gel equilibrated in Tris–borate electrophoresis buffer containing
ethidium bromide (50 g/ml). Gels were photographed under UV light.
Results
Elevated in vitro migration and invasion properties in C-81 LNCaP cells
The metastatic potential of human prostate cancer cells was analyzed by in vitro Matrigel
Boyden chamber assay. As compared to C-33 LNCaP cells, the C-81 cells showed a
significantly higher level of motility through polyethylene terapthalate (Fig. 1A) and a higher
degree of invasion through matrigel (Fig. 1B).
MECA-79 epitope is located in mucin-type glycans
The MECA-79 epitope was detected in two protein bands at 77 and 131 kDa from lysates of
both C-33 and C-81 cells. The high passage LNCaP cells showed greater intensity (2.6-fold of
131 kDa and 1.8-fold of 77 kDa) than low passage LNCaP cells. The biochemical properties
of MECA-79 epitopes present in C-33 and C-81 cells were characterized by digestion of cell
lysates with N-glycanase, KS-II, Ch-ABC and OSGP. The MECA-79 epitope was resistant to
N-glycanase, KS-II and Ch-ABC (Data not shown). However, the two protein bands carrying
MECA-79 epitope were digested by OSGP, which specifically cleaves the peptide backbone
of glycoproteins carrying sialylated mucin type glycans (Fig. 2) [17].
L-Selectin interaction with LNCaP cells
Flow cytometry analysis showed that 70% more C-81 LNCaP cells bound to L-selectin than
C-33 cells (Fig. 3).
Analysis of glycogenes involved in the synthesis of L-selectin ligand in LNCaP cells
To understand the difference in metastatic potential as related to L-selectin ligand expression
between C-33 and C-81 LNCaP cells, a combination of western blotting and RT-PCR analysis
of key glycogenes involved in the synthesis of L-selectin ligand was performed. Western blot
analysis showed a 70% increase of the C1 3GalT-1 enzyme (core 1 synthase) in C-81 cells as
compared to C-33 cells (Fig. 4A). RT-PCR analysis of the expression of glycosyltransferase
and sulfotransferase genes involved in L-selectin ligand synthesis showed a significantly higher
expression of the following glycogenes in C-81 LNCaP cells as compared to those in C-33
cells: 3GnT-3 (120%), FUT7 (20%), GlcNAc6ST-1 (50%), ST3Gal-III (30%) and ST3Gal-
IV (30%) (Fig. 4B). There was no difference in the expression of C2GnT-1, 4GalT-1,
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4GalT-4 and iGnT genes between these two LNCaP cells although their expression levels
were relatively high in both cells.
Discussion
Cell–cell interactions involving selectins and their carbohydrate ligands present on opposite
cells play a key role in a variety of biological events, such as trafficking and homing of
lymphocytes to specific tissues or lymphoid organs in the body [18]. For example, the L-
selectin ligand in the high endothelial venues of the lymphoid organs is responsible for the
arrest of the L-selectin-carrying leukocytes that traffic through these organs. Current study
demonstrates that LNCaP cells express L-selectin ligand, which may facilitate metastasis of
these cells to the regional lymph nodes by hitching on the circulating leukocytes. This finding
is consistent with the fact that these cells are originally derived from the lymph nodes of a
patient with metastatic prostate cancer [19].
The C-33 and C-81 LNCaP cell model has been shown to mimic the clinical progression of
prostate cancer metastasis [14,15] and has been widely used for studying the mechanisms of
prostate cancer progression [20–24]. We find that C-81 cells express more L-selectin ligand
and exhibit higher levels of in vitro migratory and invasive properties as compared with C-33
cells. The results indicate that increased expression of L-selectin ligand correlates with elevated
metastatic potential of LNCaP cells. Although elevation of L-selectin ligand can be used to
explain the increased in vivo tumorigenicity, it is not clear how this property can be used to
explain the enhanced in vitro metastatic potential of LNCaP cells. One possible explanation is
that this property has nothing to do with the in vitro tumorigenicity, i.e. the observation is
simply a co-incidental phenomenon. However, we can not exclude the possibility that this L-
selectin ligand may facilitate in vitro migration of LNCaP cells because these cells express not
only L-selectin ligand but also L-selectin (Radhakrishnan, unpublished observation).
6-sulfo-sLex is the L-selectin ligand, which also can be recognized by MECA-79 antibody.
This antibody is specific for mucin core 1-associated 6-sulfo-N-acetyllactosamine [Gal 1–4
(6-sulfo)GlcNAc 1–3Gal 1–3GalNAc ] [25] with or without further modifications, which
include 2–3 sialylation of 1-4Gal, 1–3 fucosylation of GlcNAc, and/or C6 sulfation of
1-3Gal [6,7]. MECA-79 antibody specifically binds to luminal surface of HEV and inhibits
binding of lymphocytes to HEVs in vivo and in vitro [26]. MECA-79 epitope can be found in
mucin-type [17] and N-linked [27] glycans. But, they are present only in mucin-type glycans
in LNCaP cells (Fig. 2).
Mucin glycan-associated 6-sulfo-sLex can be found on extended core 1 and core 2 branch as
shown in Fig. 5. Synthesis of this epitope involves several glycosyl- and sulfo-transferases
working in a sequential ordered manner [25]. Mucin glycan synthesis is initiated by the
formation of GalNAc Ser/Thr as catalyzed by peptidyl GalNAc transferases, which is followed
by the formation of core 1 [Gal 1–3GalNAc] as catalyzed by core 1 synthase (C1 3GalT-1).
After the formation of core 2 [GlcNAc 6 (Gal 1–3)GalNAc 1R] and/or extended core 1
[GlcNAc 1–3Gal 1–3GalNAc 1R], GlcNAc 6-sulfate is generated before 1–4
galactosylation of GlcNAc. This enzymatic step is followed by sialylation and then
fucosylation to complete the synthesis of the L-selectin ligand. L-selectin ligand can be located
at core 1 and core 2, but only core 1-associated L-selectin ligand can be recognized by
MECA-79 antibody [25]. The increase in MECA-79 epitope and L-selectin ligand in C-81
LNCaP cells as compared to C-33 cells can be explained by upregulation of the expression of
several glycogenes involved in the synthesis of these glycotopes. C-81 cells express 70% more
C1 3GalT-1 than C-33 cells. Since core 1 is the obligatory precursor for core 2 [28], more
core 1 may lead to the synthesis of more core 2 branch. In addition, C81 cells express 120%
more core 1 extension enzyme ( 3GnT-3), which may lead to the production of more extended
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core 1 structure. Furthermore, C-81 cells express more sulfotransferase (GlcNAc6ST-1),
sialyltransferases (ST3Gal-III and -IV) and fucosyltransferase (FUT7). The expression pattern
of these glycosyltransferases positively correlates with higher level expression of MECA-79
epitope and L-selectin ligand on C-81 cells than in C-33 cells. Furthermore, it is of interest to
note that alteration of the expression of selective glycosyltransferase and sulfo-transferase
genes is correlated with the metastatic potential of LNCaP cells, suggesting the important role
played by these glycogenes in carcinogenesis. The role of each of these glycogenes plays in
this process will be examined in vivo in an animal model. Further, some of these genes may
serve as prognostic markers for cancer progression. Modulation of the expression of these
genes may be used as a potential therapeutic approach to suppress cancer metastasis.
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Migration and invasion analysis of LNCaP cells. C-81 and C-33 LNCaP cells of 5 × 104 cells/
ml medium were inoculated in the upper chambers of 24-well migration and matrigel invasion
chamber plates. After 22–24 h, the cells that transversed to bottom side of the chamber plates
were fixed, stained, and then counted under a phase contrast microscope (40×) in three
independent fields for each insert. C-81 cells showed highly significant level of migration (a)
and invasion (b) than C-33 cells through polyethylene terapthalate membrane and matrigel
invasion chambers, respectively. The data, which were expressed as mean±SD, were obtained
from three independent experiments (**p<0.05 and ***p<0.001)
Radhakrishnan et al. Page 8


















































Western blot analysis and characterization of MECA-79 epitopes on C-33 and C-81 LNCaP
cells. Two bands of 77 and 131 were recognized as MECA-79 epitopes. The high passage
LNCaP cells showed more intense bands than low passage LNCaP cells. The lysates treated
with OSGP showed loss of MECA-79 epitopes
Radhakrishnan et al. Page 9


















































Selectin-ligand interaction on LNCaP cells. The high passage LNCaP cells showed 1.7 fold
higher numbers of cells that binding to L-selectin than low passage LNCaP cells. The data
represented an average of three independent experiments (**p<0.01)
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Western blotting of C1 3GalT-1 (a) and RT-PCR analysis of the expression of sulfotransfease
and other glycosyltransferase genes involved in the biosynthesis of mucin-type L-selectin
ligand (b). 3GnT-3, GlcNAc6ST-1, FUT7, ST3Gal-III and -IV genes were expressed higher
in C-81 than C-33 LNCaP cells. There was no difference in the expression of C2GnT-1,
4galT-1, 4galT-4 and iGnT genes between these two LNCaP cells
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Schematic diagram of the biosynthetic pathway of 6-sulfo-sLex located on biantennary mucin
glycans. Key glycosyltransferases and sulfotransferase involved in the biosynthesis of 6-sulfo-
sLex on extended core 1 and core 2 branch structures are shown. [ppGalNAcTF, peptidyl N-
acetylgalactosaminyltransferase; 3Gal-T1, 3-Galactosyltransferase-1; C2GnT-1, 1-6N-
acetlyglucosaminyltransferase-1; GlcNAc6ST1, N-acetlyglucosaminyl-6-O-
sulfotransferase-1; 4GalT-4, 4-Galactosyltransferase-4; FUT-7, 1–3 Fucosyltransferase-7;
ST3Gal-III/IV, 2–3 sialyltransferase-III/IV; 3GlcNAcT-3, 3-N-
acetlyglucosaminyltransferase-3; 4GalT, 4-galactosyltransferase]
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